Nov 2010 21

Career: Scientist and Entrepreneur (Technology Pioneer 2010 by WEF), Founder and CEO Aura Biosciences
Interests: Art, Music, Travel, Languages, Photography, Innovation, Giving Back
Hometown: Barcelona, Spain; Boston, Massachusetts, USA

Elisabet de los Pinos is Founder and CEO of Aura Biosciences, a next-generation biotechnology company seeking to greatly improve the efficacy of cancer treatment. Her career spans oncology and translational research in both biotech and large pharmaceutical settings, including Lilly Pharmaceuticals. Elisabet received a magna cum laude doctorate in Molecular Biology at the University of Barcelona. She completed part of her training at Mount Sinai School of Medicine Institute of Molecular Medicine (NY-USA) and at Georgetown School of Medicine (Washington DC). Following that, she worked as a post-doctoral Fellow at the Institute of Cancer Research in London (UK). She has a Master degree in Business Administration from European IE Business School and is a graduate of the Entrepreneurship Development Program at the Massachusetts Institute of Technology (MIT).

Aura Biosciences, is a next-generation biotech company developing the Nanosmart(tm) platform for the delivery of nano-enabled drugs. Nanosmart solves critical issues in drug delivery by encapsulating therapies within protein nanoparticles engineered for precise targeting, immune system evasion, and efficient cellular uptake. Aura is applying Nanosmart to two important areas, the well-studied area of chemotherapeutics and the emerging field of RNAi. With an initial focus on cancer, Aura’s goal is to increase patient survival rates by making chemotherapy better tolerated and more efficacious. The company was recognized in 2009 as a Technology Pioneer by the World Economic Forum and is located in Cambridge, Massachusetts.


Other articles/links/videos:
Time Magazine: Tech Pioneers Who Will Change Your Life
Bloomberg Businessweek: Aura Biosciences Targets a New Era of Cancer Drugs (2009/12)
YouTube by WEF / Technology Pioneer 2010: Delivering the Next Generation of Nano-embeded Drugs

Short intro to Aura Biosciences:

Leave a Comment